Hysterectomy - A Regional Intervention Study (HYSTERI)

February 24, 2022 updated by: Preben Kjolhede, MD, professor, University Hospital, Linkoeping

The Effect of Systematic Preoperative Preparation on the Outcome of Benign Hysterectomy: a Prospective Intervention Study

Approximately 4,000 procedures with hysterectomy for benign indication are performed annually in Sweden. There are large differences in preoperative information, planning of surgery and surgical technique. A structured approach including the use of mobile phone technology can possibly improve patient information and patient involvement. Our purpose is to to evaluate whether systematic preoperative preparation improves the outcome of elective hysterectomy on benign indication.

Study Overview

Detailed Description

Background Approximately 4,000 procedures with hysterectomy for benign indication are performed annually in Sweden. There are large differences between clinics in Sweden in the proportion of hysterectomies conducted using minimally invasive surgery. There is no uniformity in the planning of surgery. Patient-reported outcome measures, such as satisfaction and postoperatively unexpected symptoms, are important in assessing the outcome of surgery. Patient-reported measurements are, besides other factors, dependent on preoperative information. Mobile phone technology can possibly improve patient information and patient involvement.

Purpose

To evaluate whether a systematic preoperative preparation improves the outcome of elective hysterectomy on benign indication. The work consists of three parts with the following purposes:

Sub-study 1: To evaluate the effect of a preoperative algorithm for determining the most appropriate method of hysterectomy on the proportion undergoing surgery as a minimally invasive procedure and on the frequency of complications.

Sub-study 2: To compare patient-reported outcome measures, including unexpected symptoms, recovery, and satisfaction, in women who receive systematic preoperative information from specially trained staff and a mobile application with targeted education on the procedure, with women who receive information according to normal routines.

Sub-study 3: To investigate how women experience digitized information via a mobile application in connection with surgery.

Participating centers Departments of obstetrics and gynecology at the hospitals in Norrköping, Jönköping, Eksjö, Värnamo, Västervik, Kalmar and Växjö.

Schedule The study starts in September 2020. Recruitment of patients is planned to take two years.

Study Type

Interventional

Enrollment (Anticipated)

320

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women 18 - 55 years old.
  • Women undergoing hysterectomy for benign indication.
  • Women with ASA 1 - 3.
  • Women who understand and can express themselves in Swedish.
  • Women who, by signing "Informed Consent", agree to participate in the study after written and oral information.
  • Women who participate and respond to the surveys in the GynOp register.
  • Women who have access to an I-phone, smartphone, computer or tablet and who can use the study-specific mobile application. (Does not apply to sub-study 1).

Exclusion criteria

  • Women where both ovaries are removed during the operation.
  • Women undergoing hysterectomy for prolapse indication.
  • Women undergoing hysterectomy for cancer prophylactic indication.
  • Women undergoing hysterectomy for gender reassignment purposes.
  • Women with intellectual disabilities to such an extent that they can not fill in the relevant questionnaires etc. or if they do not understand the meaning of participating in the study or where there may be ethical doubts about the patient's participation in the study.
  • Women who have a mental illness of such severity that the doctor in charge considers it inappropriate for the patient to be included in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intensified preoperative information
The patient participating in the intervention group is evaluated preoperatively based on an algorithm. This information is designed according to a checklist which includes how the procedure is performed, rules of conduct in connection with and after the procedure and what the patient can expect after surgery.
The doctor takes a medical history and examines the patient according to regular routines, but uses the algorithm as support in deciding on the surgical method. After the doctor's visit, the patient must see a research nurse to receive the intensified preoperative information about hysterectomy. This information is designed according to a checklist. The patient can also download a mobile application. The study-specific mobile application (app) contains information about hysterectomy. The information is structured in three parts - Before the Operation, At the Hospital and After the Operation. A timeline describes the activities and events that occur before, around and after the operation. Within each section there are several information links, with eg checklists.
No Intervention: Control group
The patient who participates in the control group receives information about participation in the study as a control, ie without information about the intervention. The patient will then be planned for the procedure according to current, local routines.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Unexpected postoperative symtoms
Time Frame: Up to one year postoperatively
Proportion of patients with unexpected symptoms.
Up to one year postoperatively
Proportion minimally invasive hysterectomy
Time Frame: Retrospecive data 5 years before study start until completion of prospective study
Proportion of women undergoing hysterectomy as a minimally invasive procedure
Retrospecive data 5 years before study start until completion of prospective study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complication
Time Frame: Up to one year postoperatively
Numbers of and types of patient reported complications
Up to one year postoperatively
Lenght of stay
Time Frame: Day of surgery until discharge from hospital pre- and during the intervention
Hospital length of stay in connection with surgery
Day of surgery until discharge from hospital pre- and during the intervention
Sick leave
Time Frame: Day of discharge from hospital after surgery until return to normal work, maximal one year
return to work measured as actual sick leave length
Day of discharge from hospital after surgery until return to normal work, maximal one year
Recovery
Time Frame: Day of surgery until normal ADL, maximal one year
time to normal daily activity (ADL)
Day of surgery until normal ADL, maximal one year
Health related quality of life
Time Frame: Preoperatively up to one year postoperatively
Measured with EuroQol EQ-5D-3L health index comprising of two parts. Part A Scale -0.5941 to 1. A higher number indicates better quality of life. Part B. EuroQol visual analoque scale EQ-VAS. Scale 0-100. A higher number indicates better quality of life
Preoperatively up to one year postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Preben Kjölhede, MD PhD, University Hospital, Linköing
  • Study Chair: Lollo Makdessi, MD, Vrinnevi Hospital, Norrköping

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 4, 2020

Primary Completion (Anticipated)

August 31, 2022

Study Completion (Anticipated)

November 30, 2023

Study Registration Dates

First Submitted

February 4, 2022

First Submitted That Met QC Criteria

February 15, 2022

First Posted (Actual)

February 24, 2022

Study Record Updates

Last Update Posted (Actual)

March 14, 2022

Last Update Submitted That Met QC Criteria

February 24, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • HYSTERI

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Benign Hysterectomy

Clinical Trials on Intiensified structured perioperative information

3
Subscribe